Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.

L Peyrin-BirouletP BossuytD BettenworthE V LoftusS I AnjieG D'HaensM SarutaP ArkkilaH ParkD ChoiD- H KimWalter Reinisch

Published in: Digestive diseases and sciences (2024)

Subcutaneous infliximab showed a favorable efficacy profile for achieving clinical remission and endoscopic outcomes during maintenance treatment in CD or UC.

Keyphrases

patients with inflammatory bowel disease
ulcerative colitis
systematic review
rheumatoid arthritis
randomized controlled trial
systemic lupus erythematosus
young adults
skeletal muscle
insulin resistance
endoscopic submucosal dissection